Plus Therapeutics, Inc. ( PSTV) - Key Metrics
PSTV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q3 | $0.01 | -$0.04 | -$0.02 | -$0.02 |
| 2025Q2 | $0.03 | $0.11 | -$0.12 | -$0.12 |
| 2025Q1 | $0.07 | -$1.19 | -$0.42 | -$0.42 |
PSTV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -17.44 |
| 2025Q3 | ? | -4.15 |
| 2025Q2 | ? | 0.82 |
| 2025Q1 | ? | -0.20 |
PSTV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -26.15% | ? |
| 2025Q4 | -15.77% | ? |
| 2025Q3 | -3506.47% | ? |
| 2025Q2 | -34482.76% | ? |
| 2025Q1 | -44621.40% | ? |
PSTV
Price: $5.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 21.45 USD
P/E Ratio: 0.30
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 204800
Market Capitalization: 44.1 million